checkAd
    Startseite > Aktien > Devonian Health Group > Nachrichten
    Devonian Health Group Aktie
    0,1950
     
    CAD
    -20,41 %
    -0,0500 CAD
    Letzter Kurs 02.05.24 TSX Venture
    0,1950
     
    CAD
    500 STK
    Geldkurs 03.05.24
    0,2500
     
    CAD
    108.500 STK
    Briefkurs 03.05.24
    ISIN: CA2518341078 · WKN: A2P8GJ · SYM: GSD · Kanada

    Neueste Nachrichten

    Devonian Announces Closing of a Private Placement of Units
    14.03.24 · Business Wire (engl.) · Devonian Health Group
    Devonian Announces that its Subsidiary, Altius, Launches Authorized Generic of Dexlansoprazole (Dexilant) in Canada
    27.02.24 · Business Wire (engl.) · Devonian Health Group
    Devonian Announces a $2.16 Million Secured Term Loan Following Repayment of $3.5 Million Long Term Loan
    26.02.24 · Business Wire (engl.) · Devonian Health Group
    Devonian Announces the Results of its Annual General and Special Shareholders' Meeting, the Approval of Amendments to its Stock Option Plan, and Grant of Stock Options
    21.02.24 · Business Wire (engl.) · Devonian Health Group
    Devonian Seeks Shareholders Approval for Share Consolidation
    19.01.24 · Business Wire (engl.) · Devonian Health Group
    Devonian Bolsters Leadership Team and Aligns Strategy to Accelerate Clinical Development and Drive Revenue Growth and Commercial Success
    04.12.23 · Business Wire (engl.) · Devonian Health Group
    Devonian Files Patent Cooperation Treaty (PCT) Application for Thykamine in Wound Healing
    08.11.23 · Business Wire (engl.) · Devonian Health Group
    Devonian Announces Closing of a Private Placement of $500,000
    01.09.23 · Business Wire (engl.) · Devonian Health Group
    Devonian Health Group Receives a Notice of Allowance for Issuance of a U.S. Patent On a Method of Treatment of Inflammatory Bowel Disease.
    20.06.23 · Business Wire (engl.) · Devonian Health Group
    Devonian Announces Closing of a Private Placement of $1.2 Million
    07.06.23 · Business Wire (engl.) · Devonian Health Group
    Devonian Announces Private Placement of up to $5 Million
    19.05.23 · Business Wire (engl.) · Devonian Health Group
    Devonian Health Group Announces Presentation of Thykamine Efficacy Results in Atopic Dermatitis at the World Congress of Dermatology and Provides Thykamine Clinical Development Program Update.
    16.05.23 · Business Wire (engl.) · Devonian Health Group